35,888 results on '"platelet activation"'
Search Results
2. Platelet hyperresponsiveness and increased platelet-neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension.
- Author
-
Duler, Laetitia, Visser, Lance, Nguyen, Nghi, Johnson, Lynelle, Stern, Joshua, and Li, Ronald
- Subjects
clinical pathology ,hematology ,immunothrombosis ,platelet function ,pulmonary thromboembolism ,respiratory tract ,serotonin ,Dogs ,Animals ,Dog Diseases ,Hypertension ,Pulmonary ,Male ,Female ,Blood Platelets ,Prospective Studies ,Platelet Activation ,Neutrophils ,Thrombelastography ,Serotonin ,Echocardiography ,Mitral Valve Insufficiency - Abstract
BACKGROUND: Pulmonary hypertension (PH) in dogs with myxomatous mitral valve disease (MMVD) is caused by increased pulmonary venous pressure. Thrombosis, vascular remodeling, and vasoconstriction mediated by platelets could exacerbate PH. HYPOTHESIS: Dogs with PH will exhibit a hypercoagulable state, characterized by increased platelet activation, platelet-leukocyte, and platelet-neutrophil aggregate formation. ANIMALS: Eleven dogs (≥3.5 kg) diagnosed with MMVD and PH and 10 dogs with MMVD lacking PH. METHODS: Prospective cohort ex vivo study. All dogs underwent echocardiographic examination, CBC, 3-view thoracic radiographs, and heartworm antigen testing. Severity of PH and MMVD were assessed by echocardiography. Viscoelastic monitoring of coagulation was assessed using thromboelastography (TEG). Platelet activation and platelet-leukocyte/platelet-neutrophil interactions were assessed using flow cytometry. Plasma serotonin concentrations were measured by ELISA. RESULTS: Unstimulated platelets from dogs with MMVD and PH expressed more surface P-selectin than MMVD controls (P = .03). Platelets from dogs with MMVD and PH had persistent activation in response to agonists. The number of platelet-leukocyte aggregates was higher in dogs with MMVD and PH compared with MMVD controls (P = .01). Ex vivo stimulation of whole blood resulted in higher numbers of platelet-neutrophil aggregates in dogs with MMVD and PH (P = .01). Assessment of hypercoagulability based on TEG or plasma serotonin concentrations did not differ between groups. CONCLUSION AND CLINICAL IMPORTANCE: Platelet hyperresponsiveness and increased platelet-neutrophil interaction occur in dogs with MMVD and PH, suggesting that platelets play a role of in the pathogenesis of PH. Clinical benefits of antiplatelet drugs in dogs with MMVD and PH require further investigation.
- Published
- 2024
3. Deciphering Abnormal Platelet Subpopulations in COVID-19, Sepsis and Systemic Lupus Erythematosus through Machine Learning and Single-Cell Transcriptomics
- Author
-
Qiu, Xinru, Nair, Meera G, Jaroszewski, Lukasz, and Godzik, Adam
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Medicinal and Biomolecular Chemistry ,Chemical Sciences ,Microbiology ,Infectious Diseases ,Precision Medicine ,Machine Learning and Artificial Intelligence ,Hematology ,Clinical Research ,Autoimmune Disease ,Genetics ,Lupus ,Inflammatory and immune system ,Good Health and Well Being ,Humans ,COVID-19 ,Lupus Erythematosus ,Systemic ,Blood Platelets ,Machine Learning ,Single-Cell Analysis ,Transcriptome ,Sepsis ,SARS-CoV-2 ,Gene Expression Profiling ,Platelet Activation ,sepsis ,platelets ,single-cell RNA-seq ,machine learning ,Other Chemical Sciences ,Other Biological Sciences ,Chemical Physics ,Biochemistry and cell biology ,Medicinal and biomolecular chemistry - Abstract
This study focuses on understanding the transcriptional heterogeneity of activated platelets and its impact on diseases such as sepsis, COVID-19, and systemic lupus erythematosus (SLE). Recognizing the limited knowledge in this area, our research aims to dissect the complex transcriptional profiles of activated platelets to aid in developing targeted therapies for abnormal and pathogenic platelet subtypes. We analyzed single-cell transcriptional profiles from 47,977 platelets derived from 413 samples of patients with these diseases, utilizing Deep Neural Network (DNN) and eXtreme Gradient Boosting (XGB) to distinguish transcriptomic signatures predictive of fatal or survival outcomes. Our approach included source data annotations and platelet markers, along with SingleR and Seurat for comprehensive profiling. Additionally, we employed Uniform Manifold Approximation and Projection (UMAP) for effective dimensionality reduction and visualization, aiding in the identification of various platelet subtypes and their relation to disease severity and patient outcomes. Our results highlighted distinct platelet subpopulations that correlate with disease severity, revealing that changes in platelet transcription patterns can intensify endotheliopathy, increasing the risk of coagulation in fatal cases. Moreover, these changes may impact lymphocyte function, indicating a more extensive role for platelets in inflammatory and immune responses. This study identifies crucial biomarkers of platelet heterogeneity in serious health conditions, paving the way for innovative therapeutic approaches targeting platelet activation, which could improve patient outcomes in diseases characterized by altered platelet function.
- Published
- 2024
4. In vitro and in silico analyses of Lippia alba (Verbenaceae) essential oil as an inhibitor of dengue virus and platelet activation.
- Author
-
Silva-Trujillo, Lina, Ocazionez, Raquel E., Quintero-Rueda, Elizabeth, Stashenko, Elena E., Rondón-Villarreal, Paola, and Solarte-David, Victor A.
- Subjects
- *
DENGUE viruses , *ESSENTIAL oils , *BLOOD platelet activation , *LIPPIA (Genus) , *VIRUS inhibitors - Abstract
Dengue virus (DENV) causes millions of infections each year, and there are currently no approved antivirals. Essential oils could serve as potential candidates for developing plant-based dengue treatments. Lippia alba (Mill.) N.E. Brown essential oil (LAEO) was selected to investigate the mode of antiviral action and its effect on activated platelets. Binding affinities of 20 LAEO compounds and platelet proteins were investigated through docking analyses. LAEO showed a potent virucidal effect (IC50, 2.1 to 5.1 μg/mL) against all DENV serotypes. LAEO reduced P-selectin (from 61% to 18%) and increased survival (from 71% to 97%) in DENV-2- and DENV NS1-stimulated human platelets. Sesquiterpene hydrocarbons showed the highest binding affinities (from −7.3 to −8.0 kcal/mol) with platelet innate immune receptors such as TLR2/1, TLR4/MD-2 and αIIbβ3 integrin. The data provide a first step towards defining the potential of LAEO as a candidate for developing phytotherapeutics for dengue. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Differences in human and commercial hybrid pig platelet activation induced by borosilicate glass beads in a modified chandler loop-system.
- Author
-
Christer, T., Hüner, A., Robering, J.W., Mrowietz, C., and Hiebl, B.
- Subjects
- *
PLATELET count , *BOROSILICATES , *CLINICAL trials , *BLOOD platelet activation , *GLASS beads - Abstract
The pig (
Sus scrofa ) is the most widely used large animal model in Europe, with cardiovascular research being one of the main areas of application.Adequate refinement of interventional studies in this field, meeting the requirements of Russell and Burch’s 3 R concept, can only be performed if blood-contacting medical devices are hemocompatible.Because most medical devices for cardiovascular interventional procedures are developed for humans, they are tested only for compatibility with human blood.The aim of this study was therefore to determine whether there are differences in behavior of human and porcine platelets from commercial hybrid pigs when they come into contact with borosilicate glass, which was used as an exemplary thrombogenic material.For this purpose, changes in platelet count, platelet volume and platelet expression of the activation markers CD61, CD62P and CD63 were measured using a modified chandler loop-system simulating the fluidic effects of the bloodflow.Commercial hybrid pig and human platelets showed significant adhesions to borosilicate glass but the commercial hybrid pigs platelets showed a significantly higher tendency to adhere to borosilicate glass.In contrast to human platelets the platelets of commercial hybrid pigs showed significant activation after 4 to 8 minutes exposure to borosilicate glass and there were differences among the ratios of surface and activation markers in between the platelets of both species. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Complexity of Platelet-Rich Plasma: Mechanism of Action, Growth Factor Utilization and Variation in Preparation.
- Author
-
Pineda-Cortel, Maria Ruth, Suarez, Consuelo, Cabrera, Jan-Tyrone, Daya, Minerva, Bonifacio, Rinnel Brenan L., Vergara, Renz Cleve, Dacanay, Aleth Therese L., and Villavieja, Adrian
- Subjects
- *
WOUND healing , *CYTOLOGY , *VASCULAR endothelial growth factors , *PLATELET-derived growth factor , *PLATELET-rich plasma , *BLOOD platelets , *SOMATOMEDIN , *CELL separation , *TRANSFORMING growth factors-beta - Abstract
Platelet-rich plasma (PRP) is an autologous blood-derived product utilized nowadays as a treatment for various non-hemostatic, orthopedic, and muscular injuries. Although the exact mechanism of PRP use and effectivity is not yet fully understood, PRP applications are extensively developing and expanding. PRP, as the name implies, contains mostly platelets; thus, platelets are the main players in this therapeutic management for numerous tissue disorders and conditions. Platelets are known to facilitate wound healing and tissue repair through the various growth factors present in their granules. The growth factors in platelets also act on cells found in tissues other than those involved in wound repair, resulting in an increased interest in PRP use as a regenerative therapy for various disorders. In this paper, we discussed platelets and its morphology, and the various growth factors present within the platelet granules. The effects of these growth factors on tissue recovery are highlighted. PRP components, preparation considerations and classifications are presented here to showcase PRP differences and complexity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Assessing the Effect of Magnetite Nanoflowers on Platelets in a Multiscale Approach in the Context of Thromboembolic Diseases.
- Author
-
Colombo, Monika, Meng, Yingchao, Poirier-Quinot, Marie, Rollet, Anne-Laure, Geeverding, Audrey, Delcea, Mihaela, deMello, Andrew J., and Abou-Hassan, Ali
- Abstract
Iron oxide magnetic nanoparticles have emerged as promising theranostic agents for the treatment of cardiovascular diseases. Using a multiscale approach, we investigated the interaction of 26.5 nm diameter multicore magnetite nanoflowers, recognized for being excellent nanoheaters and contrast agents in nanomedicine, with human blood platelets. Using flow cytometry, we determined safe concentrations of magnetite nanoflowers. Data indicated that platelets exhibit reversible activation at high magnetite nanoflower concentrations. Magnetic resonance imaging revealed significant reductions in T
1 and T2 relaxation times when platelets were combined with magnetite nanoflowers at high concentrations suggesting nanoparticle–platelet interaction. At the nanoscale, transmission and scanning electron microscopy confirmed morphological changes in platelets when exposed to a high concentration of nanoparticles and their partial internalization in the platelets. Overall, the findings support the theranostic potential of magnetite nanoflowers in whole blood for thromboembolic disease management, with the potential for future investigations over longer exposure. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
8. Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study.
- Author
-
Roux, Crystal G., Mason, Shayne, du Toit, Louise D. V., Nel, Jan-Gert, Rossouw, Theresa M., and Steel, Helen C.
- Subjects
- *
MACROPHAGE inflammatory proteins , *ACETOACETIC acid , *GRANULOCYTE-macrophage colony-stimulating factor , *PROTON magnetic resonance , *ADENOSINE monophosphate - Abstract
Antiretroviral therapy (ART) has reduced the mortality and morbidity associated with HIV. However, irrespective of treatment, people living with HIV remain at a higher risk of developing non-AIDS-associated diseases. In 2019, the World Health Organization recommended the transition from efavirenz (EFV)- to dolutegravir (DTG)-based ART. Data on the impact of this transition are still limited. The current study therefore investigated the metabolic profiles, cytokine inflammatory responses, and platelet activation before and after the treatment transition. Plasma samples from nine virally suppressed adults living with HIV and sixteen healthy, HIV-uninfected individuals residing in Gauteng, South Africa were compared. Metabolite and cytokine profiles, and markers associated with platelet activation, were investigated with untargeted proton magnetic resonance metabolomics, multiplex suspension bead array immunoassays, and sandwich enzyme-linked immunosorbent assays, respectively. In those individuals with normal C-reactive protein levels, the transition to a DTG-based ART regimen resulted in decreased concentrations of acetoacetic acid, creatinine, adenosine monophosphate, 1,7-dimethylxanthine, glycolic acid, 3-hydroxybutyric acid, urea, and lysine. Moreover, increased levels of formic acid, glucose, lactic acid, myo-inositol, valine, glycolic acid, and 3-hydroxybutyric acid were observed. Notably, levels of interleukin-6, platelet-derived growth factor-BB, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor–alpha, soluble cluster of differentiation 40 ligand, as well as regulated on activation, normal T-cell expressed and secreted (RANTES) reached levels close to those observed in the healthy control participants. The elevated concentration of macrophage inflammatory protein-1 alpha was the only marker indicative of elevated levels of inflammation associated with DTG-based treatment. The transition from EFV- to DTG-based regimens therefore appears to be of potential benefit with metabolic and inflammatory markers, as well as those associated with cardiovascular disease and other chronic non-AIDS-related diseases, reaching levels similar to those observed in individuals not living with HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Dietary omega-3 fatty acids modulate the production of platelet-derived microvesicles in an in vivo inflammatory arthritis model.
- Author
-
Laevski, Angela M., Doucet, Mélina R., Doucet, Marco S., LeBlanc, Audrée A., Pineau, Paskale E., Hébert, Mathieu P. A., Doiron, Jérémie A., Roy, Patrick, Mbarik, Maroua, Matthew, Alexis J., Allain, Eric P., Surette, Marc E., and Boudreau, Luc H.
- Subjects
- *
BIOLOGICAL models , *CHEMOKINES , *RESEARCH funding , *OMEGA-3 fatty acids , *RHEUMATOID arthritis , *UNSATURATED fatty acids , *IN vivo studies , *FISH oils , *BLOOD platelets , *MICE , *ANIMAL experimentation , *INFLAMMATION , *WESTERN diet , *CYTOKINES , *COMPARATIVE studies , *DIETARY supplements , *DIET , *DISEASE progression , *PHENOTYPES - Abstract
Purpose: The aim of this study was to investigate the effects of different ω-3 polyunsaturated fatty acid (PUFA) enriched diets, including a novel renewable plant source of ω-3 fatty acids (Buglossoides arvensis), on the development and progression of rheumatoid arthritis (RA). Methods: RA was induced in mice consuming experimental diets using the K/BxN model. The experimental diets consisted of either a western control diet (control), diets containing B. arvensis oil or fish oil. The effects of the diets on platelets, platelet microvesicles (PMVs), and inflammatory markers such as clinical index, ankle thickness and cytokine/chemokine release were measured. Results: While ω-3 PUFA-enriched diets did not prevent the development of arthritis in the K/BxN model, a significant decrease in ankle swelling was observed compared to the control group. Platelets isolated from mice consuming either low content of B. arvensis oil or fish oil diets exhibited significantly decreased PMVs production compared to mice consuming the control diet. Conclusion: Our study provides insight into the contribution of ω-3 PUFA supplementation in modulating the pro-inflammatory phenotype of platelets in RA pathology. Furthermore, our study suggests that low concentrations of dietary B. arvensis oil may have similar anti-inflammatory potential seen with dietary fish oil supplementation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Comprehensive analysis of L-PRF exudate components and their impact on whole blood platelets.
- Author
-
Melo-Ferraz, António, Coelho, Cristina, Miller, Paulo, Criado, Maria Begoña, and Monteiro, Maria Céu
- Abstract
Objective: This study assessed the cellular composition and effects of leukocyte-platelet-rich fibrin (L-PRF) exudate on whole blood platelets from healthy volunteers. Key objectives included evaluating leukocyte subpopulations, platelet activation markers, platelet-leukocyte interactions and quantifying inflammatory cytokines within the L-PRF exudate. Materials and methods: L-PRF was obtained from 20 healthy donors. Flow cytometry methodologies were used to assess intracellular calcium kinetics and activated GPIIbIIIa, and P-selectin expression. Leukocyte subpopulations and platelet-leukocyte interactions were characterized using monoclonal antibodies. Inflammatory cytokines (IL-8, IL-1β, IL-6, IL-10, TNF, IL-12p70) within L-PRF exudate were quantified using a cytometric bead array. Results: The expression of activated GPIIbIIIa, and P-selectin exhibited a significant increase (p < 0.001) when L-PRF exudate was added to platelets of whole blood. Regarding intracellular Ca2+ mobilization, the L-PRF exudate elicited significant responses (p < 0.001). L-PRF exudate contained different leukocytes populations, being TCD4 + the most representative of T cells. It was possible to stablish a profile of cytokines produced by the L-PRF exudate, with human IL-8 cytokine exhibiting the highest average (16.90 pg/mL). Conclusions: Despite the study limitations, the research yielded important insights: 1- L-PRF exudate can stimulate platelet activation, essential in healing, tissue inflammation and remodeling. 2-The presence of leukocyte subpopulations within L-PRF exudate reflexes its complexity and potential to enhance immune responses. 3-The analysis of inflammatory cytokines within L-PRF exudate revealed its immunomodulatory potential. These findings are valuable evidences for understanding the potential role of L-PRF exudate in regenerative dentistry and medicine, offering innovative therapeutic strategies. Clinical relevance: This research highlights crucial aspects that could significantly influence the clinical use of L-PRF exudate in the oral cavity. The findings support the application of L-PRF exudate in both surgical and regenerative dentistry, facilitating the development of innovative therapeutic strategies to enhance patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. The Predictive Role of Hematological Parameters in Hypertension.
- Author
-
Meng, Xiangzhu, Sun, Hong, Tu, Xiaowen, and Li, Wei
- Subjects
- *
NEUTROPHIL lymphocyte ratio , *PREDICTIVE tests , *BLOOD testing , *ERYTHROCYTES , *HYPERTENSION , *CARDIOVASCULAR diseases risk factors , *MEAN platelet volume , *BLOOD platelet activation , *LIPOPROTEINS , *DISEASES , *BLOOD platelets , *INFLAMMATION , *BIOMARKERS , *DISEASE complications ,CARDIOVASCULAR disease related mortality - Abstract
Hypertension (HT) is a common chronic disease that often causes target-organ damage and severe complications, contributing to cardiovascular morbidity and mortality worldwide. Accumulating evidence suggests that inflammation plays a prominent role in the initiation and progression of HT. Multiple inflammatory biomarkers have been proposed to predict HT. Several new hematological parameters can reflect the inflammatory response and platelet activation. The major advantage of hematological parameters over conventional inflammatory markers is that they are relatively inexpensive and easily obtained from routine blood tests. Numerous studies have investigated several hematological parameters for their utility as predictive biomarkers for the diagnosis and prognosis of HT. Among them, the neutrophil to lymphocyte ratio (NLR), monocyte to high density lipoprotein cholesterol ratio (MHR), red cell distribution width (RDW), platelet to lymphocyte ratio (PLR), mean platelet volume (MPV), platelet distribution width (PDW), and systemic immune-inflammation index (SII) have recently received attention. We searched PubMed and Embase databases (up to September 18, 2022) to assess the relationships between hematological parameters and HT. This review discusses the diagnostic and prognostic value of these hematological parameters in HT, providing an important basis for early screening, risk stratification, and optimal management of hypertensive patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Can we use serum SCUBE 1 levels as a biomarker in obstructive sleep apnea hypopnea syndrome?
- Author
-
Selcuk, Omer Tarik, Ozturk Yılmaz, Gamze, Ellidag, Hamit Yasar, Ilden, Oğuzhan, Turkoglu Selcuk, Nursel, Yilmaz, Gokhan, Ensari, Nuray, Konsuk Unlu, Hande, and Eyigor, Hülya
- Subjects
SLEEP apnea syndromes ,BLOOD platelet activation ,BIOMARKERS ,SNORING ,APNEA - Abstract
Objective: To examine the SCUBE1 level, a biomarker in vascular biology that could determine the prognosis of cardiovascular events during OSA treatment. Methods: In total, 129 patients were included in the study. Thirty were diagnosed with simple snoring and 99 with OSA. Results: In males, significant correlation was determined between SCUBE1 non-REM AHI, hypopnea index, total apnea index, mean SO
2 , minimum SO2 , and < 90% saturation duration. Conclusion: Serum SCUBE1 levels increased more in male patients with severe OSA compared to other OSA levels, and high serum SCUBE1 levels were found to be associated with lower oxygen levels in OSA patients. The SCUBE1 biomarker can correlate with severe OSA in males. There was a statistically significant difference between OSA groups in terms of SCUBE1 score for male patients (p = 0.002) but not for females (p = 0.498). It is important that future SCUBE1 studies evaluate males vs. females. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. A novel snake venom C-type lectin-like protein modulates blood coagulation by targeting von Willebrand factor and coagulation factor IX
- Author
-
Fan-Yu Zeng, Ren-Sheng Ji, Xiao-Qin Yu, Ya-Nan Li, Qi-Yun Zhang, and Qian-Yun Sun
- Subjects
Snake venom ,C-type lectin‐like protein ,Intrinsic coagulation pathway ,Platelet activation ,Coagulation function ,Medicine ,Science - Abstract
Abstract Snake venom C-type lectin-like proteins (CLPs) belong to the nonenzymatic proteins. To date, no CLP with both platelet and coagulation factors activating activities has been reported. In this study, a novel CLP, termed protocetin, with molecular weight of 29.986 kDa, was purified from the Protobothrops mucrosquamatus venom (PMV). It consists of α- and β-chains, with 67% similarity in their N-terminal sequence. Protocetin activates glycoprotein Ib (GPIb) by binding to von Willebrand factor (vWF), inducing platelet aggregation. It also activates the intrinsic coagulation pathway by binding to coagulation factor IX. After injection of protocetin into mice at dose of 0.5 µg/g or 1.5 µg/g, it resulted in activation of platelets, a notable reduction in platelet count and prolonged tail bleeding time. Additionally, the plasma activated partial thromboplastin time (APTT) was significantly extended, and the fibrinogen concentration was markedly reduced. Thrombelastogram comfirmed the anticoagulation effect of protocetin. Notably, no microthrombosis was observed in tissues of lung, liver and kidney within 1 h after injection of protocetin into the mice at dose of 0.5 µg/g. This study revealed protocetin as a novel CLP from PMV that has dual functions in activating platelet and coagulation factor IX, thereby modulates coagulation in vivo. This work contributes to a better understanding of the structure and function of snake venom CLP.
- Published
- 2024
- Full Text
- View/download PDF
14. Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors
- Author
-
Mobbs, Jesse I, Black, Katrina A, Tran, Michelle, Burger, Wessel AC, Venugopal, Hariprasad, Holman, Theodore R, Holinstat, Michael, Thal, David M, and Glukhova, Alisa
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Hematology ,Clinical Research ,Development of treatments and therapeutic interventions ,5.1 Pharmaceuticals ,United States ,Humans ,Cryoelectron Microscopy ,Platelet Activation ,Arachidonic Acid ,Arachidonate 12-Lipoxygenase ,Thrombocytopenia ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Paediatrics and Reproductive Medicine ,Immunology ,Biochemistry and cell biology ,Cardiovascular medicine and haematology ,Paediatrics - Abstract
Human 12-lipoxygenase (12-LOX) is a key enzyme involved in platelet activation, and the regulation of its activity has been targeted for the treatment of heparin-induced thrombocytopenia. Despite the clinical importance of 12-LOX, the exact mechanisms by which it affects platelet activation are not fully understood, and the lack of structural information has limited drug discovery efforts. In this study, we used single-particle cryo-electron microscopy to determine high-resolution structures (1.7-2.8 Å) of human 12-LOX. Our results showed that 12-LOX can exist in multiple oligomeric states, from monomer to hexamer, which may affect its catalytic activity and membrane association. We also identified different conformations within the 12-LOX dimer, which likely represent different time points in its catalytic cycle. Furthermore, we identified small molecules bound to 12-LOX. The active site of the 12-LOX tetramer was occupied by an endogenous 12-LOX inhibitor, a long-chain acyl coenzyme A. In addition, we found that the 12-LOX hexamer can simultaneously bind to arachidonic acid and ML355, a selective 12-LOX inhibitor that has passed a phase 1 clinical trial for the treatment of heparin-induced thrombocytopenia and received a fast-track designation by the Food and Drug Administration. Overall, our findings provide novel insights into the assembly of 12-LOX oligomers, their catalytic mechanism, and small molecule binding, paving the way for further drug development targeting the 12-LOX enzyme.
- Published
- 2023
15. Preferential and sustained platelet activation in COVID-19 survivors with mental disorders
- Author
-
Norma Maugeri, Rebecca De Lorenzo, Mario Gennaro Mazza, Mariagrazia Palladini, Fabio Ciceri, Patrizia Rovere-Querini, Angelo A. Manfredi, and Francesco Benedetti
- Subjects
Mood disorders ,Platelet activation ,COVID-19 ,Medicine ,Science - Abstract
Abstract Pre-existing mental disorders are considered a risk factor for severe COVID-19 outcomes, possibly because of higher vascular burden. Moreover, an unconventional platelet activation characterizes COVID-19 and contributes to inflammatory and thrombotic manifestations. In the light of the inflammation theory of mental disorders, we hypothesized that patients with mental disorders could be sensitive to the SARS-CoV-2 elicited platelet activation. We investigated platelet activation in 141 COVID-19 survivors at one month after clearance of the virus, comparing subjects with or without an established pre-existing diagnosis of mental disorder according to the DSM-5. We found that platelets from patients with a positive history of psychiatric disorder underwent unconventional activation more frequently than conventional activation or no activation at all. Such preferential activation was not detected when platelets from patients without a previous psychiatric diagnosis were studied. When testing the effects of age, sex, and psychiatric history on the platelet activation, GLZM multivariate analysis confirmed the significant effect of diagnosis only. These findings suggest a preferential platelet activation during acute COVID-19 in patients with a pre-existing psychiatric disorder, mediated by mechanisms associated with thromboinflammation. This event could have contributed to the higher risk of severe outcome in the psychiatric population.
- Published
- 2024
- Full Text
- View/download PDF
16. Red ginseng extract inhibits lipopolysaccharide-induced platelet–leukocyte aggregates in mice
- Author
-
Yuan Yee Lee, Sung Dae Kim, Jin-Kyu Park, Won-Jae Lee, Jee Eun Han, Min-Soo Seo, Min-Goo Seo, Seulgi Bae, Dongmi Kwak, Evelyn Saba, and Man Hee Rhee
- Subjects
Platelet activation ,Platelet–leukocyte aggregates ,Red ginseng extract ,Inflammation ,Thrombosis ,Botany ,QK1-989 - Abstract
Background: Platelet–leukocyte aggregates (PLAs) play important roles in cardiovascular disease and sepsis. Red ginseng extract (RGE) has been well-studied for its antiplatelet and anti-inflammatory activities. However, the potential inhibitory effects of RGE on PLA have not been investigated. Methods: Six-week-old ICR mice were given oral gavage of RGE for 7 days, followed by an intraperitoneal injection of 15 mg/kg of lipopolysaccharide. Mice were euthanized 24 h later, and blood samples were collected for further analysis. Flow cytometry was utilized to sort populations of PLAs and platelet–neutrophil aggregates (PNAs). By using confocal microscopy, PNAs were validated. Morphological changes in platelets and leukocytes were visualized with scanning electron microscopy. Expressions of tissue factor (TF) and platelet factor 4 (PF4) were investigated using enzyme-linked immunosorbent assay. Results: Populations of activated platelets, PLAs and PNAs, were significantly increased with LPS-induction. Treatment with 200 and 400 mg/kg of RGE decreased platelet activation. Moreover, the populations of PLAs and PNAs were reduced. PNAs were visible in the blood of septic mice, and this was attenuated by treatment with 400 mg/kg of RGE. Morphologically, sepsisinduced platelet activation and fibrin formation in the blood. This was reduced with RGE treatment. Sepsis-induced increase in the plasma levels of TF and PF4 was also reduced with RGE treatment. Conclusion: This study shows that RGE is a potential therapeutic that reduces the activation of platelets and targets PLA and PNA formation. Detailed inhibitory mechanisms of RGE should be studied.
- Published
- 2024
- Full Text
- View/download PDF
17. Designing an experimental method for assessing biocompatibility of circuit coatings using biomarkers for platelet activation during cardiopulmonary bypass
- Author
-
Sancheti Meghal, Rentschler Mitchell, Bolch Charlotte, Li Weidang, Necco Katelyn, Rath Thomas, Esfandiarei Mitra, and Darban Nathaniel
- Subjects
cardiopulmonary bypass ,platelets ,biomarkers ,platelet activation ,elisa ,circuit coating ,Medicine - Abstract
Introduction: Cardiopulmonary bypass is an essential component of cardiothoracic surgeries. However, significant complications such as systemic inflammatory response syndrome (SIRS) resulting from cardiopulmonary bypass (CPB) are a common occurrence due to contact between circulating blood and foreign surfaces that leads to platelet activation. It is suggested that different available CPB circuit coatings can potentially reduce platelet activation. However, there have been no published evidence-based reports confirming these claims. In addition, there is no well-established protocol for studying platelet activation biomarkers during CPB in vitro in a laboratory setting. Methods: CPB was simulated in the laboratory using bovine blood in two different types of coated CPB circuits: Trillium® Biosurface by Medtronic, and XcoatingTM Surface by Terumo. Fresh bovine blood samples were collected and circulated through the CPB circuit following the standard protocol used in the operation rooms. Blood samples were then collected at 5 min, 30 min, and 55 min during the circulation. Blood plasmas were separated and subjected to enzyme-linked immunosorbent assay to measure most established platelet activation markers P-selectin, Platelet Factor 4 (PF4), Glycoprotein IIb/IIIa (GPIIb/IIIa), and β-thromboglobulin (β-TG) at different time points. Results: The biomarker values at 30 min and 55 min were compared to the base values at 5 min for each type of CPB circuit. The results of the means from all measured biomarkers showed data measurements that indicated no significant variability within each coating. All collected data points fell within ±2 SD of the means, which was considered acceptable variations across technical replicates. Conclusion: In this study, we were able to establish an in vitro protocol in the laboratory setting that is precise and reliable with minimum intra-variability. This established protocol will allow for future studies in which different coated CPB circuits can be compared for their effectiveness in blocking platelet activation during the CPB.
- Published
- 2024
- Full Text
- View/download PDF
18. 血小板活化在急性脑梗死中的作用研究进展 Research Progress on the Role of Platelet Activation in Acute Cerebral Infarction
- Author
-
张建村,王新星,仝海波
- Subjects
血小板活化 ,平均血小板体积 ,血小板分布宽度 ,急性脑梗死 ,platelet activation ,mean platelet volume ,platelet distribution width ,acute cerebral infarction ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
摘要: 急性脑梗死是常见的缺血性脑血管病,与血小板活性密切相关。血小板活性在急性脑梗死发病、进展、治疗及预后等环节均存在重要影响。平均血小板体积(mean platelet volume,MPV)和血小板分布宽度(platelet distribution width,PDW)是反映血小板活性的两个重要指标,体积大的血小板因能分泌更多的促血栓因子、表达更多的P-选择素和血小板糖蛋白Ⅱb/Ⅲa受体而被认为拥有更高的活性;活化的血小板因伸出大小不一的伪足而使得PDW增大,因此高MPV值和高PDW值都是血小板活化的标志。本文对血小板活化对急性脑梗死的发生、发展及预后等方面的影响进行综述,以期为后续研究血小板活性和急性脑梗死的关系提供参考。 Abstract: Acute cerebral infarction is a common ischemic cerebrovascular disease and is closely related to platelet activity. Platelet activity has significant impact on occurrence, development, treatment and prognosis of acute cerebral infarction. Mean platelet volume (MPV)and platelet distribution width (PDW) are two important indicators that reflect platelet activity. Platelets with larger volume are considered to have higher activity for they can secrete more thrombosis factors and express more P-selections and platelet glycoprotein Ⅱb/Ⅲa receptors. Activated platelets increase PDW by protruding pseudopodia of varying sizes. Thus, both high MPV and PDW are the indications of platelet activation. This paper reviewed the effects of platelet activation on the occurrence, development and prognosis of acute cerebral infarction, in order to provide references for the subsequent study of the relationship between platelet activity and acute cerebral infarction.
- Published
- 2024
- Full Text
- View/download PDF
19. Characterization of a novel mouse platelet transfusion model.
- Author
-
Gordy, Dominique, Swayne, Theresa, Berry, Gregory J., Thomas, Tiffany A., Hudson, Krystalyn E., and Stone, Elizabeth F.
- Subjects
- *
BLOOD platelet transfusion , *ADENOSINE diphosphate , *BACTERIAL contamination , *PLATELET-rich plasma , *MICE - Abstract
Background and Objectives: Platelet transfusions are increasing with medical advances. Based on FDA criteria, platelet units are assessed by in vitro measures; however, it is not known how platelet processing and storage duration affect function in vivo. Our study's aim was to develop a novel platelet transfusion model stored in mouse plasma that meets FDA criteria adapted to mice, and transfused fresh and stored platelets are detectable in clots in vivo. Study Design and Methods: Platelet units stored in mouse plasma were prepared using a modified platelet‐rich plasma (PRP) collection protocol. Characteristics of fresh and stored units, including pH, cell count, in vitro measures of activity, including activation and aggregation, and post‐transfusion recovery (PTR), were determined. Lastly, a tail transection assay was conducted using mice transfused with fresh or stored units, and transfused platelets were identified by confocal imaging. Results: Platelet units had acceptable platelet and white cell counts and were negative for bacterial contamination. Fresh and 1‐day stored units had acceptable pH; the platelets were activatable by thrombin and adenosine diphosphate, agreeable with thrombin, had acceptable PTR, and were present in vivo in clots of recipients after tail transection. In contrast, 2‐day stored units had clinically unacceptable quality. Conclusion: We developed mouse platelets for transfusion analogous to human platelet units using a modified PRP collection protocol with maximum storage of 1 day for an 'old' unit. This provides a powerful tool to test how process modifications and storage conditions affect transfused platelet function in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Platelets: Physiology and Biochemistry.
- Author
-
Jurk, Kerstin and Kehrel, Beate E.
- Subjects
- *
BLOOD platelets , *BLOOD platelet aggregation , *BLOOD cells , *BIOCHEMISTRY , *PHYSIOLOGY - Abstract
This article represents a republication of an article originally published in STH in 2005. This republication is to help celebrate 50 years of publishing for STH. The original abstract follows. Platelets are specialized blood cells that play central roles in physiologic and pathologic processes of hemostasis, inflammation, tumor metastasis, wound healing, and host defense. Activation of platelets is crucial for platelet function that includes a complex interplay of adhesion and signaling molecules. This article gives an overview of the activation processes involved in primary and secondary hemostasis, for example, platelet adhesion, platelet secretion, platelet aggregation, microvesicle formation, and clot retraction/stabilization. In addition, activated platelets are predominantly involved in cross-talk to other blood and vascular cells. Stimulated "sticky" platelets enable recruitment of leukocytes at sites of vascular injury under high shear conditions. Platelet-derived microparticles as well as soluble adhesion molecules, sP-selectin and sCD40L, shed from the surface of activated platelets, are capable of activating, in turn, leukocytes and endothelial cells. This article focuses further on the new view of receptor-mediated thrombin generation of human platelets, necessary for the formation of a stable platelet–fibrin clot during secondary hemostasis. Finally, special emphasis is placed on important stimulatory and inhibitory signaling pathways that modulate platelet function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Correlation between inflammatory markers and platelet metrics in predicting ischemic stroke outcomes.
- Author
-
Pavithran, Prisina, Prabhakar, Anju, Salim, Shabana, and Akbar, Ashna Kallingal
- Subjects
ISCHEMIC stroke ,THROMBIN receptors ,ACUTE phase proteins ,STROKE patients ,HEMORRHAGIC stroke ,BLOOD platelet aggregation - Published
- 2024
- Full Text
- View/download PDF
22. Noninvasive Biomarkers for Alcohol-Related Liver Disease—A Proteomic Related Preliminary Report.
- Author
-
Nelaturi, Prabhudas, Kademani, Sangeetha P., Siva Subramanian, Vithiavathi, and Ravikumar, Sambandam
- Abstract
Increased alcohol intake over decades leads to progressive alcohol-related liver disease (ALD) and contributes to increased mortality. It is characterized by reduced platelet count. Platelets have a role in protecting vascular integrity and involved in liver regeneration. Alcohol affects the platelet count and its function. Platelet function is regulated by their proteins, released during pathophysiological conditions. Therefore, platelet proteome plays a vital role during ALD. This preliminary study consists of 10 patients with ALD. It includes the preparation of human platelets for the proteomic approach. We performed liquid chromatography-mass spectrometry for the samples. A total of 536 proteins were identified in patients with ALD of which 31 proteins were mentioned as a candidate based on their clinical significance. The advancement of diagnostic or therapeutic tools based on the application of platelet proteins in ALD is still far off. Platform for platelet and its proteome research may give diagnostic and prognostic insights into ALD. Platelet proteomes could possibly be concluded as therapeutic and potential diagnostic or prognostic markers in ALD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Nicotine addiction and an elevated cholesterol level exhibit negative effects on platelet activation in patients with chronic Buerger's Disease.
- Author
-
Nowaczyńska, Aleksandra, Zubilewicz, Tomasz, Sokołowska, Bożena, Terlecki, Piotr, Szymczyk, Agnieszka, and Hus, Iwona
- Subjects
BLOOD platelet activation ,NICOTINE addiction ,THROMBIN receptors ,BLOOD platelet aggregation ,ADENOSINE diphosphate - Abstract
Introduction: Buerger's Disease (BD), or thromboangiitis obliterans (TAO), is a vasculoocclusive disorder of unknown etiology. Cigarette smoking is considered to be the main risk factor for the development of TAO. This study aimed to assess the activation of platelets in patients with BD compared to a control group. Materials and methods: Thirty patients (24 men and six women, median age 51.4 years) with TAO were included in the study. In the control group there were 20 healthy adults (16 men and four women, median age 44.0 years). Platelet activation was measured by light aggregometry and flow cytometry methods with and without platelet activators, such as thrombin receptor agonist peptide (TRAP-6) and adenosine diphosphate (ADP). Results: The velocity and intensity of aggregation increased in patients with TAO (p <0.05). MFI (mean fluorescence intensity) of P-selectin, CD63 (GP53-component of lysosomal membrane), and PAC-1 (platelet activation complex-1) on platelets increased in patients (p <0.05). Significantly higher aggregation velocities were noted in smoking patients in response to collagen (Coll) and to arachidonic acid (AA) compared to non-smoking ones. Aggregation velocity in response to AA was higher in heavy smokers compared to all smokers. A significantly higher intensity of aggregation was found in moderate smokers in response to epinephrine (EPI) and AA compared to non-smoking ones. A positive correlation between cholesterol concentrations and its fractions (LGL, TG), and platelet aggregation and the MFI of platelets, was found in patients with an increased cholesterol level. The aggregation velocity with EPI and AA was negatively correlated with HDL level. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. تاثیر انواع مختلف دستگاههای پلاکت فرزیس بر پارامترهای کیفی واحدهای پلاکت تولیدی.
- Author
-
سمانه صادقی نیسی and صدیقه امینی کافی
- Subjects
- *
LEUCOCYTES , *BLOOD platelet aggregation , *ERYTHROCYTES , *QUALITY control , *PLATELETPHERESIS , *BLOOD platelets , *SYSTEMATIC reviews , *MEDLINE , *BLOOD sugar , *LACTATES , *ONLINE information services , *HEMAPHERESIS , *CARBON dioxide - Abstract
Background and Objectives Plateletpheresis is the collection of platelets from a donor using an apheresis device. There are different types of apheresis devices used for plateletpheresis, and each device can have an impact on the quality of platelet concentrates produced. This review article aims to investigate the effect of plateletpheresis devices on the quality parameters of produced platelet units. Materials and Methods This article reviewed the effects of different apheresis devices on the quality of platelet units by searching keywords in PubMed, Google Scholar, Science Direct, and Scopus databases and used 83 related articles. Results To evaluate the quality of the plateletpheresis concentrates, various parameters such as platelet count and yield, WBC and RBC count, platelet aggregation, metabolic activity, platelet activity, and the number of platelets microparticles are evaluated. The platelet counts in platelet concentrates obtained from apheresis devices follow AABB and European standards. In examining the metabolic activity of apheresis platelets in most studies, the level of glucose and pO2 decreased, lactate and pCO2 increased, and pH was within acceptable limits. When comparing platelet aggregation with different agonists, the platelet unit from the Amicus device showed the lowest response, while Trima Accel showed the highest response. Moreover, Amicus reported a higher level of platelet activation and microparticle production, whereas the lowest level of both belonged to Trima Accel. Conclusions The quality of the plateletpheresis concentrate can be affected by the apheresis device. Although most available devices can provide platelet concentrates in accordance with the existing standards. According to the studies, the Trima Accel device provides a higher quality platelet concentrate than other devices (Haemonetics MCS+, Amicus, Cobe Spectra, Fresenius). [ABSTRACT FROM AUTHOR]
- Published
- 2024
25. Exploring the diagnostic potential of mean platelet volume and C-reactive protein levels in ischemic stroke patients.
- Author
-
Pavithran, Prisina, Prabhakar, Anju, Salim, Shabana, and Akbar, Ashna Kallingal
- Subjects
ISCHEMIC stroke ,MEAN platelet volume ,C-reactive protein ,STROKE patients ,BLOOD platelet aggregation ,FEVER ,TRANSIENT ischemic attack - Published
- 2024
- Full Text
- View/download PDF
26. Immature platelets and platelet reactivity in patients with acute ST-segment Elevation Myocardial Infarction using whole blood flow cytometry with SYTO-13 staining.
- Author
-
Pedersen, Oliver Buchhave, Hvas, Anne-Mette, Nissen, Peter H., Pasalic, Leonardo, Kristensen, Steen Dalby, and Grove, Erik Lerkevang
- Subjects
- *
ST elevation myocardial infarction , *BLOOD flow , *FLOW cytometry , *BLOOD platelets , *BLOOD platelet aggregation - Abstract
Reduced effect of antiplatelet therapy has been reported in patients with ST-segment elevation myocardial infarction (STEMI). Multiple factors may concur to explain this, including increased amount of highly reactive immature platelets. To investigate the association between immature platelets and reactivity determined with multicolour flow cytometry using the SYTO-13 dye in STEMI patients. We conducted an observational study of 59 patients with acute STEMI. Blood samples were obtained within 24 h after admission and after loading doses of dual antiplatelet therapy. For comparison, samples were obtained from 50 healthy individuals. Immature platelets and platelet reactivity were investigated using multicolour flow cytometry including the SYTO-13 dye that binds to platelet RNA and thus provides a method for subdividing platelets into immature and mature platelets. Additionally, we assessed platelet aggregation, serum-thromboxane B 2 levels and standard immature platelet markers. Immature platelets were more reactive than mature platelets in both STEMI patients and healthy individuals (p -values < 0.05). STEMI patients had lower platelet aggregation and thromboxane B 2 levels than healthy individuals. We found a positive association between automatically determined immature platelet markers and CD63 expression on activated platelets (Spearman's rho: 0.27 to 0.58, p -values < 0.05). Our study shows that immature platelets identified with a multicolour flow cytometric method using the SYTO-13 dye are more reactive than mature platelets in patients with acute STEMI and in healthy individuals. The presence of immature platelets may be important for the overall platelet reactivity, which may have implications for the effect of antiplatelet therapy. We included 59 patients diagnosed with acute ST-segment elevation myocardial infarction (STEMI) and 50 healthy individuals. Following blood sampling, we utilized whole blood multicolor flow cytometry, incorporating the SYTO-13 dye, which binds to platelet RNA. This approach allows us to subdivide platelets into immature and mature, enabling a comprehensive assessment of platelet reactivity across distinct platelet subpopulations. [Display omitted] • Reduced effect of antiplatelet therapy is observed in acute STEMI patients. • Immature platelets may influence platelet reactivity and the effect of antiplatelet therapy. • Results provided by a multicolour flow cytometric method using the SYTO-13 dye. • Immature platelets were more reactive than mature platelets in STEMI patients. • This study emphasizes the importance of immature platelets for the overall platelet reactivity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Prognostic gene landscapes and therapeutic insights in sepsis-induced coagulopathy.
- Author
-
Ran, Xiaoli, Zhang, Jun, Wu, Yinyu, Du, Yunxia, Bao, Daiqin, Pei, Haoyu, Zhang, Yue, Zhou, Xiaoqiong, Li, Rui, Tang, Xu, She, Han, and Mao, Qingxiang
- Subjects
- *
CELL communication , *BLOOD coagulation , *DISEASE risk factors , *BLOOD coagulation disorders , *OVERALL survival , *PROGNOSIS , *OPTICAL communications - Abstract
Sepsis is a common and critical condition encountered in clinical practice that can lead to multi-organ dysfunction. Sepsis-induced coagulopathy (SIC) significantly affects patient outcomes. However, the precise mechanisms remain unclear, making the identification of effective prognostic and therapeutic targets imperative. The analysis of transcriptome data from the whole blood of sepsis patients, facilitated the identification of key genes implicated in coagulation. Then we developed a prognostic model and a nomogram to predict patient survival. Consensus clustering classified sepsis patients into three subgroups for comparative analysis of immune function and immune cell infiltration. Single-cell sequencing elucidated alterations in intercellular communication between platelets and immune cells in sepsis, as well as the role of the coagulation-related gene FYN. Real-time quantitative PCR determined the mRNA levels of critical coagulation genes in septic rats' blood. Finally, administration of a FYN agonist to septic rats was observed for its effects on coagulation functions and survival. This study identified four pivotal genes—CFD, FYN, ITGAM, and VSIG4—as significant predictors of survival in patients with sepsis. Among them, CFD, FYN, and ITGAM were underexpressed, while VSIG4 was upregulated in patients with sepsis. Moreover, a nomogram that incorporates the coagulation-related genes (CoRGs) risk score with clinical features of patients accurately predicted survival probabilities. Subgroup analysis of CoRGs expression delineated three molecular sepsis subtypes, each with distinct prognoses and immune profiles. Single-cell sequencing shed light on heightened communication between platelets and monocytes, T cells, and plasmacytoid dendritic cells, alongside reduced interactions with neutrophils in sepsis. The collagen signaling pathway was found to be essential in this dynamic. FYN may affect platelet function by modulating factors such as ELF1, PTCRA, and RASGRP2. The administration of the FYN agonist can effectively improve coagulation dysfunction and survival in septic rats. The research identifies CoRGs as crucial prognostic markers for sepsis, highlighting the FYN gene's central role in coagulation disorders associated with the condition and suggesting novel therapeutic intervention strategies. [Display omitted] • Found four key genes for sepsis prognosis linked to coagulation. • Created sepsis survival nomogram combining gene scores and clinical data. • Unveiled three sepsis subtypes with unique prognoses and immune traits. • Showed potential of FYN agonist in treating sepsis-induced coagulopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Investigation of the role of von Willebrand factor in shear‐induced platelet activation and functional alteration under high non‐physiological shear stress.
- Author
-
Han, Dong, Sun, Wenji, Clark, Kiersten P., Griffith, Bartley P., and Wu, Zhongjun J.
- Subjects
- *
BLOOD platelet aggregation , *VON Willebrand factor , *BLOOD platelet activation , *SHEARING force , *BLOOD groups , *THROMBIN receptors , *MEDICAL equipment - Abstract
Background: von Willebrand factor (vWF) plays a crucial role in physiological hemostasis through platelet and subendothelial collagen adhesion. However, its role in shear‐induced platelet activation and functional alteration under non‐physiological conditions common to blood‐contacting medical devices (BCMDs) is not well investigated. Methods: Fresh healthy human blood was treated with an anti‐vWF antibody to block vWF–GPIbα interaction. Untreated blood was used as a control. They were exposed to three levels of non‐physiological shear stress (NPSS) (75, 125, and 175 Pa) through a shearing device with an exposure time of 0.5 s to mimic typical shear conditions in BCMDs. Flow cytometric assays were used to measure the expression levels of PAC‐1 and P‐Selectin and platelet aggregates for platelet activation and the expression levels of GPIbα, GPIIb/IIIa, and GPVI for receptor shedding. Collagen/ristocetin‐induced platelet aggregation capacity was characterized by aggregometry. Results: The levels of platelet activation and aggregates increased with increasing NPSS in the untreated blood. More receptors were lost with increasing NPSS, resulting in a decreased capacity of collagen/ristocetin‐induced platelet aggregation. In contrast, the increase in platelet activation and aggregates after exposure to NPSS, even at the highest level of NPSS, was significantly lower in treated blood. Nevertheless, there was no notable difference in receptor shedding, especially for GPIIb/IIIa and GPVI, between the two blood groups at the same level of NPSS. The block of vWF exacerbated the decreased capacity of collagen/ristocetin‐induced platelet aggregation. Conclusions: High NPSS activates platelets mainly by enhancing the vWF–GPIbα interaction. Platelet activation and receptor shedding induced by high NPSS likely occur through different pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. A tight interplay between platelet activation and mitochondrial DNA release promotes platelet storage lesion in platelet concentrates.
- Author
-
Haeri, Kamand, Samiee, Shahram, Beigi, Peyman, Hajati, Smerdis, and Deyhim, Mohammad Reza
- Subjects
- *
BLOOD platelet activation , *MITOCHONDRIAL DNA , *BLOOD platelets , *MEAN platelet volume , *PLATELET count - Abstract
Background and Objectives: Platelet storage lesion (PSL) adversely affects the quality of platelet concentrates (PCs). Platelets are prone to activation during storage. Moreover, elevated free mitochondrial DNA (mtDNA) levels in PCs are associated with a higher risk of adverse transfusion reactions. Therefore, we aimed to evaluate the correlation between platelet activation markers and mtDNA release during PC storage. Materials and Methods: Six PCs prepared by the platelet‐rich plasma method were assessed for free mtDNA copy number using quantitative real‐time PCR and CD62P (P‐selectin) expression by flow cytometry on days 0 (PC collection day), 3, 5 and 7 of storage. Lactate dehydrogenase (LDH) activity, pH, platelet count, mean platelet volume (MPV) and platelet distribution width (PDW) were measured as well. The correlation between free mtDNA and other PSL parameters, and the correlation between all parameters, was determined. Results: Significant increases in free mtDNA, MPV and PDW, and a significant decrease in platelet count and pH were observed. CD62P expression and LDH activity elevated significantly, particularly on storage days 5–7 and 0–3, respectively. Moreover, a moderate positive correlation (r = 0.61) was observed between free mtDNA and CD62P expression. The r values between free mtDNA and LDH, pH, platelet count, MPV and PDW were 0.81, −0.72, −0.49, 0.81 and 0.77, respectively. Conclusion: The interplay between platelet activation and mtDNA release in promoting PSL in PCs may serve as a promising target for future research on applying additive solutions and evaluating the quality of PCs to improve transfusion and clinical outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Platelet Biorheology and Mechanobiology in Thrombosis and Hemostasis: Perspectives from Multiscale Computation.
- Author
-
Tuna, Rukiye, Yi, Wenjuan, Crespo Cruz, Esmeralda, Romero, JP, Ren, Yi, Guan, Jingjiao, Li, Yan, Deng, Yuefan, Bluestein, Danny, Liu, Zixiang Leonardo, and Sheriff, Jawaad
- Subjects
- *
RHEOLOGY (Biology) , *COMPUTATIONAL biology , *BLOOD platelet activation , *HEMOSTASIS , *BLOOD platelets , *BLOOD platelet aggregation - Abstract
Thrombosis is the pathological clot formation under abnormal hemodynamic conditions, which can result in vascular obstruction, causing ischemic strokes and myocardial infarction. Thrombus growth under moderate to low shear (<1000 s−1) relies on platelet activation and coagulation. Thrombosis at elevated high shear rates (>10,000 s−1) is predominantly driven by unactivated platelet binding and aggregating mediated by von Willebrand factor (VWF), while platelet activation and coagulation are secondary in supporting and reinforcing the thrombus. Given the molecular and cellular level information it can access, multiscale computational modeling informed by biology can provide new pathophysiological mechanisms that are otherwise not accessible experimentally, holding promise for novel first-principle-based therapeutics. In this review, we summarize the key aspects of platelet biorheology and mechanobiology, focusing on the molecular and cellular scale events and how they build up to thrombosis through platelet adhesion and aggregation in the presence or absence of platelet activation. In particular, we highlight recent advancements in multiscale modeling of platelet biorheology and mechanobiology and how they can lead to the better prediction and quantification of thrombus formation, exemplifying the exciting paradigm of digital medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. 血小板活化在急性脑梗死中的作用 研究进展.
- Author
-
张建村, 王新星, and 仝海波
- Abstract
Copyright of Chinese Journal of Stroke is the property of Chinese Journal of Stroke Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
32. Biofilm-dispersed pneumococci induce elevated leukocyte and platelet activation
- Author
-
Yashuan Chao, Martina Mørch, Anders P. Håkansson, and Oonagh Shannon
- Subjects
leukocyte activation ,monocytes ,neutrophils ,platelets ,platelet activation ,Streptococcus pneumoniae ,Microbiology ,QR1-502 - Abstract
IntroductionStreptococcus pneumoniae (the pneumococcus) effectively colonizes the human nasopharynx, but can migrate to other host sites, causing infections such as pneumonia and sepsis. Previous studies indicate that pneumococci grown as biofilms have phenotypes of bacteria associated with colonization whereas bacteria released from biofilms in response to changes in the local environment (i.e., dispersed bacteria) represent populations with phenotypes associated with disease. How these niche-adapted populations interact with immune cells upon reaching the vascular compartment has not previously been studied. Here, we investigated neutrophil, monocyte, and platelet activation using ex vivo stimulation of whole blood and platelet-rich plasma with pneumococcal populations representing distinct stages of the infectious process (biofilm bacteria and dispersed bacteria) as well as conventional broth-grown culture (planktonic bacteria).MethodsFlow cytometry and ELISA were used to assess surface and soluble activation markers for neutrophil and monocyte activation, platelet-neutrophil complex and platelet-monocyte complex formation, and platelet activation and responsiveness.ResultsOverall, we found that biofilm-derived bacteria (biofilm bacteria and dispersed bacteria) induced significant activation of neutrophils, monocytes, and platelets. In contrast, little to no activation was induced by planktonic bacteria. Platelets remained functional after stimulation with bacterial populations and the degree of responsiveness was inversely related to initial activation. Bacterial association with immune cells followed a similar pattern as activation.DiscussionDifferences in activation of and association with immune cells by biofilm-derived populations could be an important consideration for other pathogens that have a biofilm state. Gaining insight into how these bacterial populations interact with the host immune response may reveal immunomodulatory targets to interfere with disease development.
- Published
- 2024
- Full Text
- View/download PDF
33. Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia (HITSTREAM)
- Published
- 2023
34. Tea polyphenol-derived nanomedicine for targeted photothermal thrombolysis and inflammation suppression
- Author
-
Hui Wang, Cui Tang, Yuxia Xiang, Chan Zou, Jianming Hu, Guoping Yang, and Wenhu Zhou
- Subjects
Thrombotic diseases ,Targeted delivery ,Free radical scavenging ,Photothermal therapy ,Platelet activation ,cRGD peptide ,Biotechnology ,TP248.13-248.65 ,Medical technology ,R855-855.5 - Abstract
Abstract Thrombotic diseases impose a significant global health burden, and conventional drug-based thrombolytic therapies are encumbered by the risk of bleeding complications. In this study, we introduce a novel drug-free nanomedicine founded on tea polyphenols nanoparticles (TPNs), which exhibits multifaceted capabilities for localized photothermal thrombolysis. TPNs were synthesized through a one-pot process under mild conditions, deriving from the monomeric epigallocatechin-3-gallate (EGCG). Within this process, indocyanine green (ICG) was effectively encapsulated, exploiting multiple intermolecular interactions between EGCG and ICG. While both TPNs and ICG inherently possessed photothermal potential, their synergy significantly enhanced photothermal conversion and stability. Furthermore, the nanomedicine was functionalized with cRGD for targeted delivery to activated platelets within thrombus sites, eliciting robust thrombolysis upon laser irradiation across diverse thrombus types. Importantly, the nanomedicine’s potent free radical scavenging abilities concurrently mitigated vascular inflammation, thus diminishing the risk of disease recurrence. In summary, this highly biocompatible multifunctional nanomaterial holds promise as a comprehensive approach that combines thrombolysis with anti-inflammatory actions, offering precision in thrombosis treatment.
- Published
- 2024
- Full Text
- View/download PDF
35. Impact of Platelet Hyperreactivity and Diabetes Mellitus on Ischemic Stroke Recurrence: A Single-Center Cohort Clinical Study
- Author
-
Mao Y, Zhu B, Wen H, Zhong T, and Bian M
- Subjects
ischemic stroke ,diabetes mellitus ,clopidogrel ,thrombelastography ,platelet activation ,Medicine (General) ,R5-920 - Abstract
Yusheng Mao,1,2 Bangqiang Zhu,1 Huiqin Wen,1 Tao Zhong,1 Maohong Bian1 1Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People’s Republic of China; 2Department of Blood Transfusion, The People’s Hospital of Chizhou, Chizhou, Anhui Province, People’s Republic of ChinaCorrespondence: Maohong Bian, Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui Province, 230022, People’s Republic of China, Email mhbian@ahmu.edu.cnPurpose: Ischemic stroke recurrence (ISR) is prevented by inhibiting platelet function. To investigate the impact of high on-treatment platelet reactivity (HTPR) assessed by thromboelastography (TEG) and its risk factors on ISR in individuals who have experienced acute ischemic stroke (AIS) receiving dual anti-platelet therapy (DAPT).Patients and Methods: At the end of follow-up, a total of 264 patients who met the criteria were enrolled in this cohort study. The primary endpoint event was a recurrence of ischemic stroke within 90 days of onset.Results: The ISR rate was 7.2% (19/264). The recurrence rate in the HTPR group was 15.1% (8/53), which was significantly higher than the 5.2% (11/211) in the non-HTPR group (p = 0.013), and the type 2 diabetes mellitus (T2DM) group (12.5%, 10/80) was also significantly higher compared to the non-T2DM group (4.9%, 9/184) (p = 0.028). T2DM was an isolated risk factor for HTPR (adjusted OR = 3.06, 95% CI 1.57– 5.98, P = 0.001). Kaplan-Meier plots showed that the cumulative risk (CR) of ISR was statistically different in the HTPR and T2DM groups compared to the non-HTPR group (log-rank P = 0.009) and the non-T2DM group (log-rank P = 0.026), respectively. The HTPR and T2DM groups had greater hazard ratios (HR) of ISR than the non-HTPR (adjusted HR = 2.78, 95% CI 1.06– 7.32, P = 0.038) and non-T2DM (adjusted HR = 2.64, 95% CI 1.01– 6.92, P = 0.049) groups.Conclusion: Both HTPR and T2DM are linked to ISR. Platelet Inhibition Rate (PIR) of TEG can early identify patients who are at high risk for having another ischemic stroke in patients undergoing DAPT, and this study may offer more evidence in favor of clinically personalized treatment and secondary prevention tactics.Keywords: ischemic stroke, diabetes mellitus, clopidogrel, thrombelastography, platelet activation
- Published
- 2024
36. Recurrence of macular edema in patients with branch retinal vein occlusion: a proteomic study
- Author
-
Yin Liu, Xiaohu Wang, Yonghong Sheng, Haili Jin, Linfeng Han, Jun Xu, Qingqing Fu, Jing Liu, Feng Ji, He Ding, Xiaochen Xu, KunChao Wu, Pengfei Zhang, and Guoping Wang
- Subjects
Branch retinal vein occlusion ,Macular edema ,Aqueous humor ,Proteomics ,Complement and coagulation cascades ,Platelet activation ,Ophthalmology ,RE1-994 - Abstract
Abstract Background Branch retinal vein occlusion (BRVO) is a common retinal vascular disease leading to severe vision loss and blindness. This study aimed to investigate and reveal the pathophysiological mechanisms underlying macular edema (ME) recurrence in patients with BRVO through a proteomic approach. Methods We detected proteins in the aqueous humor of 14 untreated, four refractory, and four post-operative patients with BRVO-ME and 12 age-matched cataract controls using four-dimensional label-free proteomic and bioinformatics analyses. Results In total, 84 proteins exhibited significant differential expression between the BRVO and control samples (fold change [FC] ≥ 1.2 and adjusted p-value
- Published
- 2024
- Full Text
- View/download PDF
37. Platelet Activation by a Collagen Analogue in Hemorrhagic Situations (CAPTURE)
- Published
- 2023
38. Inflammation, Platelets and Sickle Cell Disease (Il-Padre)
- Published
- 2023
39. Antiplatelet effects of the CEACAM1-derived peptide QDTT
- Author
-
Yujia Ye, Min Leng, Shengjie Chai, Lihong Yang, Longcheng Ren, Wen Wan, Huawei Wang, Longjun Li, Chaozhong Li, and Zhaohui Meng
- Subjects
Antithrombotic effects ,carcinoembryonic antigen-related cell adhesion molecule 1 ,convulxin ,peptides ,platelet activation ,Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
AbstractCarcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) restricts platelet activation via platelet collagen receptor GPVI/FcRγ-chain. In this study, screening against collagen-induced platelet aggregation was performed to identify functional CEACAM1 extracellular domain fragments. CEACAM1 fragments, including Ala-substituted peptides, were synthesized. Platelet assays were conducted on healthy donor samples for aggregation, cytotoxicity, adhesion, spreading, and secretion. Mice were used for tail bleeding and FeCl3-induced thrombosis experiments. Clot retraction was assessed using platelet-rich plasma. Extracellular segments of CEACAM1 and A1 domain-derived peptide QDTT were identified, while N, A2, and B domains showed no involvement. QDTT inhibited platelet aggregation. Ala substitution for essential amino acids (Asp139, Thr141, Tyr142, Trp144, and Trp145) in the QDTT sequence abrogated collagen-induced aggregation inhibition. QDTT also suppressed platelet secretion and “inside-out” GP IIb/IIIa activation by convulxin, along with inhibiting PI3K/Akt pathways. QDTT curtailed FeCl3-induced mesenteric thrombosis without significantly prolonging bleeding time, implying the potential of CEACAM1 A1 domain against platelet activation without raising bleeding risk, thus paving the way for novel antiplatelet drugs.
- Published
- 2024
- Full Text
- View/download PDF
40. Thromboxane biosynthesis and future events in diabetes: the ASCEND trial.
- Author
-
Petrucci, Giovanna, Buck, Georgina A, Rocca, Bianca, Parish, Sarah, Baigent, Colin, Hatem, Duaa, Mafham, Marion, Habib, Aida, Bowman, Louise, Armitage, Jane, and Patrono, Carlo
- Subjects
TYPE 2 diabetes ,TYPE 1 diabetes ,DIABETES ,BIOSYNTHESIS ,GLOMERULAR filtration rate - Abstract
Background and Aims Thromboxane (TX) A
2 , released by activated platelets, plays an important role in atherothrombosis. Urinary 11-dehydro-TXB2 (U-TXM), a stable metabolite reflecting the whole-body TXA2 biosynthesis, is reduced by ∼70% by daily low-dose aspirin. The U-TXM represents a non-invasive biomarker of in vivo platelet activation and is enhanced in patients with diabetes. This study assessed whether U-TXM is associated with the risk of future serious vascular events or revascularizations (SVE-R), major bleeding, or cancer in patients with diabetes. Methods The U-TXM was measured pre-randomization to aspirin or placebo in 5948 people with type 1 or 2 diabetes and no cardiovascular disease, in the ASCEND trial. Associations between log U-TXM and SVE-R (n = 618), major bleed (n = 206), and cancer (n = 700) during 6.6 years of follow-up were investigated by Cox regression; comparisons of these associations with the effects of randomization to aspirin were made. Results Higher U-TXM was associated with older age, female sex, current smoking, type 2 diabetes, higher body size, urinary albumin/creatinine ratio of ≥3 mg/mmol, and higher estimated glomerular filtration rate. After adjustment for these, U-TXM was marginally statistically significantly associated with SVE-R and major bleed but not cancer [hazard ratios per 1 SD higher log U-TXM (95% confidence interval): 1.09 (1.00–1.18), 1.16 (1.01–1.34), and 1.06 (0.98–1.14)]. The hazard ratio was similar to that implied by the clinical effects of randomization to aspirin for SVE-R but not for major bleed. Conclusions The U-TXM was log-linearly independently associated with SVE-R in diabetes. This is consistent with the involvement of platelet TXA2 in diabetic atherothrombosis. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
41. Platelet Dynamics in Neurodegenerative Disorders: Investigating the Role of Platelets in Neurological Pathology.
- Author
-
Cadoni, Maria Piera L., Coradduzza, Donatella, Congiargiu, Antonella, Sedda, Stefania, Zinellu, Angelo, Medici, Serenella, Nivoli, Alessandra Matilde, and Carru, Ciriaco
- Subjects
- *
NEURODEGENERATION , *BLOOD platelets , *EARLY diagnosis , *PATHOLOGY , *NEUROLOGICAL disorders , *BLOOD platelet disorders - Abstract
Background: Neurological disorders, particularly those associated with aging, pose significant challenges in early diagnosis and treatment. The identification of specific biomarkers, such as platelets (PLTs), has emerged as a promising strategy for early detection and intervention in neurological health. This systematic review aims to explore the intricate relationship between PLT dynamics and neurological health, focusing on their potential role in cognitive functions and the pathogenesis of cognitive disorders. Methods: Adhering to PRISMA guidelines, a comprehensive search strategy was employed in the PubMed and Scholar databases to identify studies on the role of PLTs in neurological disorders published from 2013 to 2023. The search criteria included studies focusing on PLTs as biomarkers in neurological disorders, their dynamics, and their potential in monitoring disease progression and therapy effectiveness. Results: The systematic review included 104 studies, revealing PLTs as crucial biomarkers in neurocognitive disorders, acting as inflammatory mediators. The findings suggest that PLTs share common features with altered neurons, which could be utilised for monitoring disease progression and evaluating the effectiveness of treatments. PLTs are identified as significant biomarkers for detecting neurological disorders in their early stages and understanding the pathological events leading to neuronal death. Conclusions: The systematic review underscores the critical role of PLTs in neurological disorders, highlighting their potential as biomarkers for the early detection and monitoring of disease progression. However, it also emphasises the need for further research to solidify the use of PLTs in neurological disorders, aiming to enhance early diagnosis and intervention strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Platelet Aggregation Studies and Coagulation Profile in Sickle Cell Disease in Symptomatic and Steady State Patients.
- Author
-
Nagose, Vaishali B., Kodate, Purnima M., Kumbhalkar, Dinkar T., Rathod, Shivanand S., and Nayak, Suprita P.
- Abstract
To determine whether there is higher degree of platelet and/ or coagulation activation in sickle cell anaemia (SS) patients in complications and with clinical risk factors. A cross sectional study was conducted at a tertiary health care centre in central India with study groups: sickle cell disease (SCD): sickle cell anaemia (SS) and sickle cell trait (AS) consisting of 100 subjects each and controls (AA) with 40 subjects. Platelet aggregation (PA) with ADP, collagen and epinephrine, PT and aPTT were performed in all subjects and PA with ristocetin in ten candidates of each group. ANOVA and student's unpaired t test were used to compare PA and coagulation profile of the three groups with respect to age groups, gender, present diagnosis, history of complications, frequency of hospital admissions (high ≥ 3/year) and frequency of blood transfusion (high > 2/year). The max PA% with ADP was significantly less in SS patients in steady state, which was even lesser in those having symptoms, complications in past/ present, high-frequency hospital admission and > 2 blood transfusions per year subgroups, as compared to all other groups and subgroups, but not consistently with collagen and epinephrine. The max PA % with ristocetin was least in SS with complications. No statistically significant difference in PT and aPTT values among the various clinical risk subgroups and groups was found. SCD patients can be monitored by using PA with ADP for their timely and better management. PA with ADP, PT and aPTT should be added to the workup of these patients for improved prognostication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. The Effect of Leukocyte Removal and Matrix Metalloproteinase Inhibition on Platelet Storage Lesions.
- Author
-
Rak-Pasikowska, Alina, Hałucha, Kornela, Sapa-Wojciechowska, Agnieszka, Wrzyszcz, Aneta, Gałuszka, Wioletta, Pęcak-Solińska, Anna, and Bil-Lula, Iwona
- Subjects
- *
MATRIX metalloproteinases , *BLOOD platelet aggregation , *BLOOD platelets , *BLOOD platelet activation , *LEUCOCYTES , *GENE expression - Abstract
The reasons for unfavorable changes in platelet concentrate (PC) quality during storage are not fully understood yet. We aimed to evaluate whether leukocytes and matrix metalloproteinases (MMPs) lead to a decrease in the quality of PCs and examine whether MMP inhibition will slow down the platelets' aging. Nine PCs were divided into three parts: (1) leukocyte-depleted (F) PCs, (2) PCs with no additional procedures (NF), and (3) PCs with the addition of an MMP inhibitor—doxycycline (D). Each PC was stored for 144 h, and a sample for testing was separated from each part on the day of preparation and after 24, 48, 72 and 144 h of storage. Blood morphological analysis, platelet aggregation, and the expression of activation markers were evaluated. MMP-2 and MMP-9 concentration, activity, and gene expression were assessed. Platelet aggregation decreased, and platelet activation marker expression increased during the storage. D concentrates showed the lowest level of platelet activation. In turn, leukocyte-depleted PCs showed the highest level of platelet activation in general. MMP-9 platelet activity was higher in leukocyte-containing concentrates at the end of the storage period. We concluded that the filtration process leads to a higher platelet activation level. The presence of doxycycline in PCs reduces the expression of the activation markers as compared to leukocyte-depleted concentrates. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Recurrence of macular edema in patients with branch retinal vein occlusion: a proteomic study.
- Author
-
Liu, Yin, Wang, Xiaohu, Sheng, Yonghong, Jin, Haili, Han, Linfeng, Xu, Jun, Fu, Qingqing, Liu, Jing, Ji, Feng, Ding, He, Xu, Xiaochen, Wu, KunChao, Zhang, Pengfei, and Wang, Guoping
- Abstract
Background: Branch retinal vein occlusion (BRVO) is a common retinal vascular disease leading to severe vision loss and blindness. This study aimed to investigate and reveal the pathophysiological mechanisms underlying macular edema (ME) recurrence in patients with BRVO through a proteomic approach. Methods: We detected proteins in the aqueous humor of 14 untreated, four refractory, and four post-operative patients with BRVO-ME and 12 age-matched cataract controls using four-dimensional label-free proteomic and bioinformatics analyses. Results: In total, 84 proteins exhibited significant differential expression between the BRVO and control samples (fold change [FC] ≥ 1.2 and adjusted p-value < 0.05). Compared to the control group, 43 and 41 proteins were upregulated and downregulated, respectively, in the BRVO group. These proteins were involved in cell adhesion, visual perception, retina homeostasis, and platelet activation. Several significantly enriched signaling pathways included complement and coagulation cascades and platelet activation. In the protein–protein interaction networks generated using the search tool for retrieval of interacting genes (STRING), the fibrinogen alpha chain and fibrinogen beta chain constituted a tightly connected cluster. Many common protein expression trends, such as the fibrinogen alpha chain and fibrinogen beta chain, were observed in both the recurrent and refractory groups. Differentially expressed proteins in the two groups were involved in complement activation, acute-phase response, platelet activation, and platelet aggregation. Important signaling pathways include the complement and coagulation cascades, and platelet activation. Protein–protein interaction analysis suggested that the fibrinogen alpha chain and fibrinogen beta chain constituted a tightly connected cluster. The expression of some differentially expressed proteins shared by the BRVO and the recurrent and refractory groups was reversed in the post-operative group. Conclusions: Our study is the first to analyze the proteomics of recurrent, refractory, and post-operative groups treated for BRVO-ME, and may potentially provide novel therapeutic interventions for the recurrence of ME. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Platelet P2Y12 signalling pathway in the dysregulated immune response during sepsis.
- Author
-
Amoafo, Emmanuel Boadi, Entsie, Philomena, Kang, Ying, Canobbio, Ilaria, and Liverani, Elisabetta
- Subjects
- *
CELLULAR signal transduction , *SEPSIS , *IMMUNE response , *BLOOD platelets , *CELL communication , *THROMBOPOIETIN receptors - Abstract
Sepsis is a complicated pathological condition in response to severe infection. It is characterized by a strong systemic inflammatory response, where multiple components of the immune system are involved. Currently, there is no treatment for sepsis. Blood platelets are known for their role in haemostasis, but they also participate in inflammation through cell–cell interaction and the secretion of inflammatory mediators. Interestingly, an increase in platelet activation, secretion, and aggregation with other immune cells (such as monocytes, T‐lymphocytes and neutrophils) has been detected in septic patients. Therefore, antiplatelet therapy in terms of P2Y12 antagonists has been evaluated as a possible treatment for sepis. It was found that blocking P2Y12 receptors decreased platelet marker expression and limited attachment to immune cells in some studies, but not in others. This review addresses the role of platelets in sepsis and discusses whether antagonizing P2Y12 signalling pathways can alter the disease outcome. Challenges in studying P2Y12 antagonists in sepsis also are discussed. LINKED ARTICLES: This article is part of a themed issue on Platelet purinergic receptor and non‐thrombotic disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.4/issuetoc [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. The Effect of Flow Field on the Initial Formation of Thrombus in Ventricular Assist Devices.
- Author
-
Meng, Kuilin, Chen, Haosheng, Zheng, Xiaobing, Pan, Yunfan, and Li, Yongjian
- Subjects
HEART assist devices ,THROMBOSIS ,INDUCTIVE effect ,BLOOD platelet activation ,SHEAR flow ,BLOOD flow - Abstract
Thrombosis is the main reason for the failure of ventricular assist devices (VADs). It has been acknowledged that the platelet activation induced by the nonphysiological blood flow leads to the increased thrombotic risk. However, due to the complicated influence of the VADs' flow field and the difficulty in real‐time in situ observation, the mechanisms and process of thrombus formation in VADs remain unclear. In this work, the process of thrombus formation in VADs in vitro experiments is observed. The thrombus is found to form on the middle of the inlet guide vanes first and it is mainly caused by the immediate activation of platelets induced by the high shear rate of the flow field around the vanes and also affected by the rotation of the impeller. Then, subsequent thrombus is found in the tail of guide vanes and around the axle journal, where the blood flow is stagnated and the platelets are activated by the accumulated bioagonists. These findings clarify that the thrombus formed on the inlet guide vanes and the axle journal are dominated by two different mechanisms. This work provides unique insights into the initial formation of the thrombus on VADs and helps to reduce the thrombotic risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Phenotypic alteration by dengue virus serotype 2 delays neutrophil apoptosis and stimulates the release of prosurvival secretome with immunomodulatory functions.
- Author
-
Rawat, Surender, Kumar, Shubham, Duggal, Shweta, and Banerjee, Arup
- Subjects
DENGUE hemorrhagic fever ,DENGUE viruses ,PHENOTYPIC plasticity ,TUMOR necrosis factor receptors ,NEUTROPHILS ,IMMUNE response ,THROMBIN receptors - Abstract
Neutrophils are the most abundant granuloytes, are phenotypically heterogeneous, and exert detrimental or protective roles during antiviral response. Dengue virus has been reported to activate neutrophils. However, the effect of the dengue virus on the neutrophil phenotypes, survival, and release of inflammatory secretome is yet to be understood. Herein, we investigated the effect of dengue virus serotype 2 (DV-2) on effector functions of naïve neutrophils and studied the impact of its secretome on different immune cells. We found that DV-2 activates purified human neutrophils and causes a significant shift toward the CD16
bright /CD62Ldim subtype in a multiplicity of infection and time-dependent manner. These phenotypically altered neutrophils show delayed apoptosis through nuclear factor κB and PI3K pathways and have decreased phagocytic capacity. Treatment of neutrophils with myeloperoxidase and PAD4 inhibitor before DV-2 incubation significantly reduced DV-2–induced double-stranded DNA release, suggesting that myeloperoxidase and PAD4 were involved at early stages for the neutrophil activation and double-stranded DNA release. We also report that DV-2–stimulated neutrophil secretome had a significant effect on viral infection, platelet activation, and naïve neutrophil survival via binding of tumor necrosis factor α to tumor necrosis factor receptor 1/2 receptors. Furthermore, incubation of endothelial cells with the DV-2–stimulated neutrophil secretome potentially inhibits proliferation and wound healing capacity and induces endothelial cell death, which can contribute to endothelial barrier dysfunction. In conclusion, the neutrophil–DV-2 interaction modulates the phenotype of neutrophils and the release of prosurvival and antiviral secretome that may act as a double-edged sword during dengue pathogenesis. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
48. Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo‐Controlled Study
- Author
-
Dimitris Kardassis, Ann‐Charlotte Egnell, Magnus Åstrand, Samuel J. Daniels, Carl Whatling, Ola Fjellström, and Anders Gabrielsen
- Subjects
cardiovascular disease ,human recombinant apyrase ,phase 1 ,platelet activation ,safety ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background ADP and ATP are importantly involved in vascular and thrombotic homeostasis, via multiple receptor pathways. Blockade of ADP P2Y12 receptors inhibits platelet aggregation and represents an effective cardiovascular disease prevention strategy. AZD3366 (APT102), a long‐acting recombinant form of an optimized CD39L3 human apyrase, has effectively reduced ATP, ADP, and platelet aggregation and provided tissue protection in preclinical models, features that could be very beneficial in treating patients with cardiovascular disease. Methods and Results We conducted this phase 1, first‐in‐human study of single ascending doses of intravenous AZD3366 or placebo, including doses added to dual antiplatelet therapy with ticagrelor and acetylsalicylic acid. The primary objective was safety and tolerability; secondary and exploratory objectives included pharmacokinetics, pharmacodynamics (measured as inhibition of platelet aggregation), adenosine diphosphatase (ADPase) activity, and ATP/ADP metabolism. In total, 104 participants were randomized. AZD3366 was generally well tolerated, with no major safety concerns observed. ADPase activity increased in a dose‐dependent manner with a strong correlation to AZD3366 exposure. Inhibition of ADP‐stimulated platelet aggregation was immediate, substantial, and durable. In addition, there was a prompt decrease in systemic ATP concentration and an increase in adenosine monophosphate concentrations, whereas ADP concentration appeared generally unaltered. At higher doses, there was a prolongation of capillary bleeding time without detectable changes in the ex vivo thromboelastometric parameters. Conclusions AZD3366 was well tolerated in healthy participants and demonstrated substantial and durable inhibition of platelet aggregation after single dosing. Higher doses prolonged capillary bleeding time without detectable changes in ex vivo thromboelastometric parameters. Registration URL: https://www.clinicaltrials.gov; Unique Identifier: NCT04588727.
- Published
- 2024
- Full Text
- View/download PDF
49. Editorial: Inflammation, the link between venous and arterial thrombosis
- Author
-
Polona Žigon and Bojing Shao
- Subjects
inflammation ,immunity ,platelet activation ,coagulation activation ,thrombosis ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
50. PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer (PLATELETSTREAM)
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.